Anticonvulsant hypersensitivity syndrome (AHS) is a delayed adverse drug reaction
associated with the use of aromatic anticonvulsant drugs. It has been most commonly …

Although the anticonvulsant hypersensitivity syndrome was first described in 1950,
confusion still abounds regarding the syndrome. The triad of fever, rash and internal organ …

Anticonvulsant hypersensitivity syndrome (AHS) is a rare, but potentially fatal, adverse
reaction that occurs in patients, including children, who are treated with anticonvulsants …

Anticonvulsant hypersensitivity syndrome is a potentially fatal drug reaction with cutaneous
and systemic reactions (incidence, one in 1000 to one in 10 000 exposures) to the arene …

Anticonvulsant hypersensitivity syndrome (AHS), characterised by fever, rash and internal
organ involvement, is a rare, but potentially fatal adverse event that occurs most commonly …

OBJECTIVE To report a case of anticonvulsant hypersensitivity syndrome (AHS) precipitated
by exposure to phenobarbital. Case Summary An 11-year-old girl receiving phenobarbital …

Anticonvulsant hypersensitivity syndrome (AHS) is an uncommon, but potentially fatal,
multisystem disorder that occurs after exposure to phenytoin, carbamazepine, or …

BACKGROUND: Aromatic anticonvulsant agents such as carbamazepine and phenytoin can
induce anticonvulsant hypersensitivity syndrome (AHS) at a frequency of 1 in 10,000 to 1 in …

Introduction: Anticonvulsant hypersensitivity syndrome (AHS) is a rare but potentially life-
threatening adverse drug reaction, primarily associated with phenytoin, phenobarbital and …

The antiepileptic drug hypersensitivity syndrome (AHS) is an adverse drug reaction
associated with the aromatic antiepileptic drugs (AEDs) phenytoin (PHT), carbamazepine …